Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Evogene Ltd (NASDAQ: EVGN) closed at $1.52 in the last session, down -16.02% from day before closing price of $1.81. In other words, the price has decreased by -$16.02 from its previous closing price. On the day, 1.42 million shares were traded.
Ratios:
We take a closer look at EVGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 0.98.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH Capital on October 08, 2021, initiated with a Buy rating and assigned the stock a target price of $7.
On July 29, 2021, Aegis Capital started tracking the stock assigning a Buy rating and target price of $10.
On December 01, 2020, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $9.Cantor Fitzgerald initiated its Overweight rating on December 01, 2020, with a $9 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.50.
Stock Price History:
Over the past 52 weeks, EVGN has reached a high of $7.19, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is 28.67%, while the 200-Day Moving Average is calculated to be -13.40%.
Shares Statistics:
A total of 6.67M shares are outstanding, with a floating share count of 6.57M. Insiders hold about 1.56% of the company’s shares, while institutions hold 7.62% stake in the company.
